Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Short-term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia
This study is not yet open for participant recruitment.
Verified June 2012
by Children's Research Institute
Study NCT01599286 Information provided by Children's Research Institute
First Received on May 11, 2012. Last Updated on June 26, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Propionic Acidemia (PA)
Methylmalonic Acidemia (MMA)
Late-onset CPS1 Deficiency (CPSD)
Additional conditions recognized in this trial
Amino Acid Metabolism, Inborn Errors
Carbamoyl-Phosphate Synthase I Deficiency Disease
Hyperammonemia
Ornithine Carbamoyltransferase Deficiency Disease
Propionic Acidemia
More general conditions related to this trial
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Metabolic Diseases
Metabolism, Inborn Errors
Mitochondrial Diseases
Nervous System Diseases
Pathologic Processes
Urea Cycle Disorders, Inborn
Interventions listed in this trial
Carbaglu
Placebo
Standard Care Treatment
Sponsors listed in this trial
Children's Research Institute
Children's Hospital of Philadelphia
Children's Hospital Boston
Case Western Reserve University
Children's Hospital Colorado
University of California, Los Angeles
University of Washington
Back to top of Main Content
